rethinkPeptides Search
Menu
Research citation

Targeting GLP-1 receptors to reduce nicotine use disorder: Preclinical and clinical evidence.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Targeting GLP-1 receptors to reduce nicotine use disorder: Preclinical and clinical evidence.

Physiology & behavior, 281, 114565

Citation

Herman, Rae J; Schmidt, Heath D. (2024). Targeting GLP-1 receptors to reduce nicotine use disorder: Preclinical and clinical evidence.. Physiology & behavior, 281, 114565. https://doi.org/10.1016/j.physbeh.2024.114565